The association between hemoglobin concentration and neurologic outcome after cardiac arrest. by Johnson, Nicholas J. et al.
Thomas Jefferson University 
Jefferson Digital Commons 
Department of Emergency Medicine Faculty 
Papers Department of Emergency Medicine 
12-1-2016 
The association between hemoglobin concentration and 
neurologic outcome after cardiac arrest. 
Nicholas J. Johnson 
University of Washington, Seattle 
Babette Rosselot 
OhioHealth 
Sarah M. Perman 
University of Colorado 
Kalani Dodampahala 
Drexel University 
Munish Goyal 
Medstar-Washington Hospital Center 
See next page for additional authors 
Follow this and additional works at: https://jdc.jefferson.edu/emfp 
 Part of the Cardiology Commons, and the Emergency Medicine Commons 
Let us know how access to this document benefits you 
Recommended Citation 
Johnson, Nicholas J.; Rosselot, Babette; Perman, Sarah M.; Dodampahala, Kalani; Goyal, 
Munish; Gaieski, David F.; and Grossestreuer, Anne V., "The association between hemoglobin 
concentration and neurologic outcome after cardiac arrest." (2016). Department of Emergency 
Medicine Faculty Papers. Paper 113. 
https://jdc.jefferson.edu/emfp/113 
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital 
Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is 
a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections 
from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested 
readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been 
accepted for inclusion in Department of Emergency Medicine Faculty Papers by an authorized administrator of the 
Jefferson Digital Commons. For more information, please contact: JeffersonDigitalCommons@jefferson.edu. 
Authors 
Nicholas J. Johnson, Babette Rosselot, Sarah M. Perman, Kalani Dodampahala, Munish Goyal, David F. 
Gaieski, and Anne V. Grossestreuer 
This article is available at Jefferson Digital Commons: https://jdc.jefferson.edu/emfp/113 
The association between hemoglobin concentration and 
neurologic outcome after cardiac arrest☆
Nicholas J. Johnson, MDa,b,*, Babette Rosselotc, Sarah M. Perman, MD, MSCEd, Kalani 
Dodampahalae, Munish Goyal, MDf, David F. Gaieski, MDg, and Anne V. Grossestreuer, MSh
aDivision of Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA
bDivision of Emergency Medicine, University of Washington, Seattle, WA
cOhioHealth, Columbus, OH
dDepartment of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO
eSchool of Public Health, Drexel University, Philadelphia, PA
fDepartment of Emergency Medicine, Medstar-Washington Hospital Center, Washington, DC
gDepartment of Emergency Medicine, Sidney Kimmel Medical College at Thomas Jefferson 
University, Philadelphia, PA
hCenter for Resuscitation Science, Department of Emergency Medicine, Perelman School of 
Medicine at the University of Pennsylvania, Philadelphia, PA
Abstract
Purpose—The purpose of the study is to determine the association between hemoglobin 
concentration (Hgb) and neurologic outcome in postarrest patients.
Methods—We conducted a retrospective cohort study using the Penn Alliance for Therapeutic 
Hypothermia (PATH) cardiac arrest registry. Inclusion criteria were resuscitated cardiac arrest 
(inhospital or out of hospital) and an Hgb value recorded within 24 hours of return of spontaneous 
circulation. The primary outcome was favorable neurologic status at hospital discharge. Survival to 
hospital discharge was a secondary outcome.
Results—There were 598 eligible patients from 21 hospitals. Patients with favorable neurologic 
outcome had significantly higher median Hgb in the first 2 hours (12.7 vs 10.5 g/dL; P < .001) and 
6 hours (12.6 vs 10.6 g/dL; P < .001) postarrest. Controlling for age, pulseless rhythm, etiology, 
location of arrest, receipt of targeted temperature management, hematologic or metastatic 
malignancy, or preexisting renal insufficiency, there was a significant relationship between Hgb 
and neurologic outcome within the first 6 hours after arrest (odds ratio, 1.23; 95% confidence 
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interval, 1.09–1.38) and survival to hospital discharge (odds ratio, 1.20; 95% confidence interval, 
1.08–1.34).
Conclusion—Higher Hgb after cardiac arrest is associated with favorable neurologic outcome, 
particularly within the first 6 hours. It is unclear if this effect is due to impaired oxygen delivery or 
if Hgb is a marker for more severe illness.
Keywords
Cardiac arrest; Postcardiac arrest syndrome; Anemia; Hemoglobin
1. Introduction
An estimated 600 000 patients have cardiac arrest in the United States each year [1]. Many 
patients who survive the initial event have the postcardiac arrest syndrome (PCAS), a 
condition characterized by ischemia-reperfusion injury leading to oxidative stress, 
neurologic injury, myocardial dysfunction, and a systemic inflammatory response [2]. 
Inhospital mortality for resuscitated patients remains high, with estimates ranging from 63% 
to 72% [2–4].
Targeted temperature management (TTM) has been shown in randomized, prospective 
clinical trials to improve outcomes for patients with postarrest anoxic encephalopathy, 
although the optimal target temperature remains controversial [5–7]. In addition to TTM, 
researchers have suggested that optimal PCAS care is a comprehensive bundle that includes 
the following: early percutaneous coronary interventions, hemodynamic optimization (goal-
directed resuscitation), low tidal volume mechanical ventilation, electrolyte management 
including glucose control, comprehensive neuromonitoring, and objective criteria for 
prognostication and withdrawal of life-sustaining therapy [8–11].
An essential component of PCAS care is optimizing oxygen delivery to the brain and other 
injured organs. Oxygen delivery is dependent both on cardiac output and arterial oxygen 
content, which is heavily influenced by the hemoglobin concentration (Hgb). Improving 
oxygen delivery to tissues by increasing the Hgb has been studied in several populations of 
critically ill patients, with the most robust trials showing that a liberal transfusion strategy is 
no better than a conservative one [12–18]. Patients with active myocardial ischemia and 
recent cardiac arrest were excluded from most of these studies, and data regarding patients 
undergoing cardiovascular surgery suggest that some subgroups might benefit from higher 
Hgb [12]. Limited data exist regarding the association between Hgb and outcome in 
resuscitated postarrest patients or whether increasing the Hgb via blood transfusion is 
associated with improvement in outcome [19–21].
The aim of this study is to investigate the relationship between Hgb and neurologic outcome 
after cardiac arrest. We hypothesize that that higher Hgb during the first 24 hours postarrest 
is associated with favorable neurologic outcome and improved survival at hospital discharge.
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2. Methods
2.1. Setting
We performed a retrospective, observational cohort study of PCAS patients from 21 member 
institutions of the Penn Alliance for Therapeutic Hypothermia (PATH) registry. The study 
was approved by the University of Pennsylvania Institutional Review Board.
2.2. Patients
The cohort included successfully resuscitated adult patients who experienced a nontraumatic 
cardiac arrest with subsequent cardiopulmonary resuscitation, achieved return of 
spontaneous circulation (ROSC), and had at least 1 recorded Hgb value within 24 hours 
postarrest. Patients were excluded if they had an active “do not resuscitate” or “do not 
intubate” order. Patients with hemorrhage as the suspected etiology for their cardiac arrest 
were excluded from the analysis.
2.3. Outcomes
The primary outcome was neurologic status at hospital discharge, measured as a Cerebral 
Performance Category (CPC) score dichotomized into “favorable” (CPC 1–2) and 
“unfavorable” (CPC 3–5). The independent variables were Hgb (main exposure), sex, race, 
age, location of cardiac arrest (inhospital or out of hospital), whether the cardiac arrest event 
was witnessed, the first detected pulseless rhythm, whether the event was of cardiac etiology, 
and whether the patient received TTM, preexisting hematologic or metastatic malignancy, or 
preexisting renal insufficiency.
2.4. Data collection
The PATH is a multicenter, Web-based national cardiac arrest registry hosted by the 
University of Pennsylvania [22]. In addition to demographic data, cardiac arrest 
characteristics, and outcomes, Hgb was abstracted for the following periods: the first 2 
hours, the first 6 hours, between 6 and 12 hours, and between 12 and 24 hours postarrest. If 
multiple Hgb values were available for a given period, the first value recorded was analyzed.
2.5. Statistical analysis
Baseline characteristics were compared using 2-tailed χ2 tests for categorical variables and t 
tests for continuous variables. The Wilcoxon rank sum test was used to compare the median 
Hgb during each of the 4 periods: the first 2 hours, the first 6 hours, between 6 and 12 hours, 
and between 12 and 24 hours postarrest. Hemoglobin concentration was investigated as a 
continuous predictor of neurologic outcome and then as a dichotomized predictor, first with 
a cutoff of 7 g/dL and again with a cutoff of 10 g/dL. These cutoffs were determined a priori 
and loosely based on prior transfusion trials in critically ill populations [12,13,15].
Multivariate logistic regression was used to test for the association between Hgb neurologic 
outcome and hospital mortality at each of the 4 time points. The analyses were adjusted for 
the following covariates: age, initial cardiac rhythm, cardiac etiology of arrest, location of 
arrest (inhospital or out of hospital), receipt of TTM, hematologic or metastatic malignancy, 
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or preexisting renal insufficiency. All analyses were conducted using STATA 12.0 (College 
Station, TX).
3. Results
3.1. Patient and cardiac arrest characteristics
There were 598 eligible patients. Mean age was 61 ± 17 years, 55% were white, 63% had an 
out-of-hospital arrest, 34% had a shockable rhythm, and 54% received TTM (Table 1). 
Patients who had a favorable neurologic outcome were more likely to be younger and male. 
They were also more likely to have the following: a witnessed cardiac arrest event, a cardiac 
etiology for their arrest, and an initial shockable rhythm.
A total of 476 patients had preexisting medical comorbidities entered into the PATH 
database (Table 2). Of these, coronary artery disease, congestive heart failure, and diabetes 
mellitus were most common. Only 6 patients had hemorrhage as a possible arrest etiology (3 
gastrointestinal bleeding, 1 postoperative hemorrhage, 1 tracheal bleeding, and 1 not 
specified). These patients were excluded from the analyses below.
3.2. Neurologic outcome
Patients with favorable neurologic outcome had significantly higher median Hgb in the first 
2 hours (12.7 vs 10.5 g/dL; P < .001) and 6 hours (12.6 vs 10.6 g/dL; P < .001) postarrest 
(Table 3). After adjusting for age, shockable rhythm, cardiac etiology, arrest location 
(inhospital vs out of hospital), receipt of TTM, malignancy, and preexisting renal 
insufficiency, there was a significant relationship between higher Hgb within the first 6 
hours after arrest and favorable neurologic outcome (odds ratio [OR], 1.23; 95% confidence 
interval [CI], 1.09–1.38) (Table 4). Each 1 g/dL increase in Hgb within the first 6 hours after 
arrest was associated with a 25% increase in the odds of having a favorable neurologic 
outcome at hospital discharge. There was no significant association between median Hgb 6 
to 12 hours or 12 to 24 hours postarrest and neurologic outcome at hospital discharge.
More patients with Hgb greater than or equal to 7 g/dL had favorable neurologic outcomes 
compared with those who had Hgb less than 7 g/dL (36.3% vs 8.8%; P < .001). These 
patients were also more likely to have an initial shockable rhythm and to be treated with 
TTM. Similarly, more patients with Hgb greater than or equal to 10 g/dL had favorable 
neurologic outcomes compared to those with Hgb less than 10 g/dL (41% vs 26%; P < .001), 
although again, there were baseline differences. Patients with Hgb greater than or equal to 
10 g/dL were more likely to be male, have an initial shockable rhythm, and not receive blood 
transfusion within the first 72 hours after cardiac arrest.
On univariate analysis, continuous as well as dichotomized Hgb with cutoffs of both greater 
than or equal to 7 g/dL and greater than or equal to 10 g/dL within the first 6 hours 
postarrest was associated with favorable neurologic outcome (Table 4). Upon adjusting for 
age, initial rhythm, cardiac etiology, arrest location, treatment with TTM, malignancy, and 
renal insufficiency, the relationship between Hgb with a cutoff of greater than or equal to 7 
g/dL was no longer significant (P = .09). The association between Hgb as a continuous 
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variable and a cutoff of greater than or equal to 10 g/dL continued to be associated with 
neurologic outcome.
3.3. Survival to hospital discharge
In unadjusted analysis, there was a significant association between continuous as well as 
dichotomized Hgb with cutoffs of both 7 and 10 g/dL and survival to hospital discharge 
(Table 5). This relationship remained significant at both 6 and 24 hours after cardiac arrest. 
Upon adjusting for age, initial rhythm, cardiac etiology, arrest location, treatment with TTM, 
malignancy, and renal insufficiency, the relationship between Hgb with a cutoff of greater 
than or equal to 7 g/dL was no longer significant at 6 hours after cardiac arrest but remained 
significant at 24 hours. The relationship between Hgb with a cutoff of greater than or equal 
to 10 g/dL remained significant at both 6 and 24 hours after cardiac arrest.
4. Discussion
This analysis of almost 600 postarrest patients from 21 hospitals in the United States 
suggests that Hgb may be associated with neurologic outcome after cardiac arrest, especially 
within the first 6 hours. The mechanism remains unclear; it is possible that Hgb affects 
neurologic outcome by augmenting oxygen delivery to ischemic tissues, or it may simply be 
a marker for severity of illness.
Although 2 recent studies have examined the association of Hgb and neurologic outcome, 
ours is unique in the following ways: it involves a large cohort of diverse patients who had 
both inhospital and out-of-hospital cardiac arrests from multiple centers, it includes patients 
treated with TTM, it analyzes Hgb at multiple time points after ROSC, and it examines how 
blood transfusion impacted this relationship [19–21]. A study published in early 2016 
examined the relationship between Hgb and neurologic outcome after out-of-hospital cardiac 
arrest among 931 patients at a single institution [21]. Although only 30 patients survived 
with good neurologic outcome, the authors found an association between a single post-
ROSC Hgb greater than or equal to 10 g/dL and favorable neurologic outcome. It is unclear 
whether these results can be generalized given a single measured Hgb and the small number 
of patients achieving the primary outcome.
A recent study of 82 patients undergoing therapeutic hypothermia after resuscitated cardiac 
arrest similarly found an association between Hgb and outcome [19]. Further analysis by 
these authors points to 1 possible mechanism. They demonstrated that Hgb bless than 10 
g/dL was associated with lower cerebral tissue oxygenation measured by near-infrared 
spectroscopy. Furthermore, these authors demonstrated that Hgb less than 12.3 g/dL was 
associated with worse neurologic outcome and that this effect was entirely driven by patients 
with low mixed venous or cerebral tissue oxygenation. Because Hgb is a central determinant 
of oxygen delivery, patients who have had cardiac arrest may be sensitive to lower Hgb and 
decreased delivery of oxygen to brain and other ischemic tissues. Furthermore, myocardial 
dysfunction is common after cardiac arrest, which may result in increased tissue oxygen 
extraction and consequent low mixed venous oxygen content [23]. This may further depress 
arterial oxygen content, an effect that may be exacerbated by anemia.
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The relationship between arterial oxygen content and outcome after cardiac arrest is 
complex. Cardiac arrest itself is a supply-dependent state, where the core tenet is to 
maximize oxygen delivery by providing chest compressions (which can provide up to 50% 
of the native cardiac output) and maximizing arterial oxygen content [24,25]. Return of 
spontaneous circulation results in a marked increase in pulmonary blood flow, rapid 
reoxygenation of ischemic tissue, and a burst in production of reactive oxygen species. This 
is the so-called oxygen paradox associated with ischemia and reperfusion. A number of 
observational studies have demonstrated an association between supranormal arterial oxygen 
tension and outcome after cardiac arrest, whereas other studies found no effect [26–31]. 
None of these previously cited studies examined the impact of Hgb or oxygen saturation, 
which accounts for greater than 95% of the arterial oxygen content under normal conditions. 
The ideal balance between optimal oxygen delivery and avoidance of oxidative damage after 
cardiac arrest remains elusive, with current guidelines recommending targeting a low-normal 
oxygen saturation of greater than or equal to 94% based on the best available data [11].
Alternatively, anemia may simply be a marker for more severe illness or a less favorable 
cardiac arrest etiology. Patients with low Hgb may have more severe preexisting chronic 
disease, less favorable cardiac arrest etiologies such as hemorrhage, or more profound 
postarrest critical illness. Preexisting anemia has been shown to be a marker of poor 
outcome among patients with other medical conditions, including those undergoing elective 
surgery and those with acute myocardial infarction [32–34]. Ample data indicate that 
patients with serious preexisting medical conditions are less likely to have a favorable 
outcome after cardiac arrest [35–41]. Furthermore, limited data suggest that patients who 
have cardiac arrest due to hemorrhage might have less favorable outcomes [42].
Limited data exist regarding transfusion after cardiac arrest. Several studies have included 
Hgb thresholds of 9 to 10 mg/dL as components of postarrest care bundles that included 
other measures such as TTM, hemodynamic optimization, ventilator management, and 
glucose control [43,44]. The impact of individual components of these bundles, including 
blood transfusion, is unclear. It is unclear whether transfusion trials in other critically ill 
populations apply to cardiac arrest patients. A landmark trial that compared transfusion 
thresholds of 7 and 9 mg/dL in 838 critically ill patients found no difference in mortality 
[15]. There was no difference in mortality among patients with cardiac disease, but the 
authors cautioned that patients with active myocardial ischemia may have been excluded due 
to preference of the treating physicians. Although this landmark trial has greatly influenced 
transfusion practices in emergency and intensive care medicine, it is unclear if these findings 
can be applied to postarrest patients.
4.1. Limitations
The PATH is large, multicenter registry with overall cardiac arrest mortality rates 
comparable to those reported throughout the United States, making our findings fairly 
generalizable. Rare missing data items exist in PATH largely because they were unavailable 
in the medical record. Given our retrospective design, only association, not causation, can be 
commented upon. It is possible that survivorship bias affected the relationship between Hgb 
and neurologic outcome, especially at later time points. Because data on blood transfusion 
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were only available for a limited subset of our population, we were not able to examine how 
blood transfusion affects this relationship.
5. Conclusion and recommendations
Higher Hgb is associated with favorable neurologic outcome in successfully resuscitated 
patients after cardiac arrest. This association is most robust within the first 6 hours. Whether 
this is effect is due to enhanced oxygen delivery or whether hemoglobin concentration is a 
marker for more severe underlying illness remains to be determined.
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Table 1
Patient characteristics according to neurologic outcome
Characteristic, n (%) All patients CPC 1–2 CPC 3–5 P
Sex
 Male 342 (57.7) 138 (69.0) 202 (52.1) <.001
 Female 251 (42.3) 62 (31.0) 186 (47.9)
Race
 White 314 (55.2) 114 (59.4) 198 (53.2) .318
 Black 221 (38.8) 69 (35.9) 149 (40.1)
 Other 34 (6.0) 9 (4.7) 25 (6.7)
Age, mean ± SD 61 ± 17 57 ± 18 63 ± 17 <.001
Location, n (%)
 Inhospital 221 (37.1) 78 (38.8) 142 (36.5) .584
 Out of hospital 374 (62.9) 123 (61.2) 247 (63.5)
Witnessed
 Yes 463 (79.7) 175 (87.9) 283 (75.1) <.001
 No 118 (20.3) 24 (12.1) 94 (24.9)
Rhythm
 Shockable 189 (34.4) 101 (55.3) 88 (24.0) <.001
 Nonshockable 361 (65.6) 81 (44.7) 278 (76.0)
Cardiac etiology
 Yes 398 (68.6) 150 (76.1) 245 (64.8) .006
 No 182 (31.4) 47 (23.9) 133 (35.2)
TTM
 Yes 318 (53.5) 105 (52.5) 211 (54.2) .688
 No 276 (46.5) 95 (47.5) 178 (45.8)
Transfusiona
 Yes 117 (32.7) 29 (23.4) 86 (37.6) .007
 No 241 (67.3) 95 (76.6) 143 (62.4)
a
Transfusion information was obtained only for a subpopulation of patients (n = 361).
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Table 2
Prearrest patient comorbidities (n = 476)
Comorbidity n (%)
Chronic respiratory failure 1 (0.2%)
Congestive heart failure 119 (25%)
Coronary artery disease 169 (36%)
Diabetes mellitus 195 (41%)
HIV 4 (0.8%)
Metastatic or hematologic malignancy 39 (8%)
Myocardial ischemia/infarction 79 (17%)
Renal insufficiency requiring dialysis 101 (21%)
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Table 3
Median hemoglobin concentrations between the neurologically favorable and unfavorable study populations at 
4 time points after cardiac arrest: the first 2 hours, the first 6 hours, 6 to 12 hours, and 12 to 24 hours
CPC 1–2, Hgba (IQR) CPC 3–5, Hgba (IQR) P
0–2 12.7 (10.3–14.6) 10.5 (8.5–12.3) <.001
0–6 12.6 (10.6–14.3) 10.45 (8.55–12.5) <.001
6–12 11.3 (9.6–13.3) 11.3 (8.7–13.4) .97
12–24 11.65 (9.46–13.05) 10.2 (8.8–12.2) .13
This table is restricted to subjects for whom complete information on serial hemoglobin concentrations was available within the first 24 hours after 
cardiac arrest (n = 453).
a
Median values are expressed as grams per deciliter.
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Table 4
Odds of favorable neurologic outcome according to dichotomized and continuous hemoglobin concentration in 
the first 6 hours after cardiac arrest (n = 392)
Hgb UnadjustedOR (95% CI)
Unadjusted
P value
Adjusted
OR (95% CI)a
Adjusted
P valuea
≥7 g/dL 4.27 (1.26–14.47) .020 3.92 (0.81–18.90) .088
≥10 g/dL 2.77 (1.76–4.37) <.001 2.30 (1.26–4.20) .007
Continuous 1.25 (1.15–1.35) <.001 1.23 (1.09–1.38) <.001
aAdjusted for age, shockable rhythm, cardiac etiology, arrest location (inhospital vs out of hospital), receipt of TTM, renal insufficiency, and 
hematologic or metastatic cancer.
J Crit Care. Author manuscript; available in PMC 2018 May 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Johnson et al. Page 14
Table 5
Odds of survival to hospital discharge according to dichotomized and continuous hemoglobin concentration 
after cardiac arrest (n = 448)
Hgb UnadjustedOR (95% CI)
Unadjusted
P value
Adjusted
OR (95% CI)a
Adjusted
P valuea
First 6 h
 ≥7 g/dL 5.04 (1.49–17.06) .009 4.74 (0.97–23.18) .055
 ≥10 g/dL 2.35 (1.53–3.60) <.001 2.05 (1.15–3.66) .015
Continuous 1.23 (1.14–1.32) <.001 1.20 (1.08–1.34) .001
First 24 h
 ≥7 g/dL 4.17 (1.43–12.16) .009 4.80 (1.02–22.53) .047
 ≥10 g/dL 1.96 (1.35–2.83) <.001 1.88 (1.13–3.11) .015
aAdjusted for age, shockable rhythm, cardiac etiology, arrest location (inhospital vs out of hospital), receipt of TTM, renal insufficiency, and 
hematologic or metastatic cancer.
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